Hadani, Rafeeda S.
HRN: 20-42-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2022
CEFUROXIME 750MG (VIAL)
06/28/2022
07/26/2022
IV
350mg
Q8h
PCAP C
Waiting Final Action